Available Assays
Method Description | Department |
---|---|
Acetazolamide | LCMS |
Acetylsalicylic acid (ASA), Salicylic acid (SAL) | LCMS |
CBD + 7OH + 7COOH metabs | LCMS |
CBD + 7OH + 7COOH + 6a-OH metabs (higher range) | LCMS |
Dabigatran | LCMS |
Dextromethorphan, Dextrorphan and 3-Methoxymorphinan | LCMS |
Diclofenac | LCMS |
Duloxetine | LCMS |
E & Z-Endoxifen | LCMS |
Entecavir | LCMS |
Estradiol and Estrone (E1, E2) | LCMS |
Glutathione (total), exploratory | LCMS |
Hydroxychloroquine, DHCQ, DCQ and BDCQ | LCMS |
Ketamine, Norketamine | LCMS |
Ketamine, Norketamine [chiral] | LCMS |
Lidocaine | LCMS |
LPA 18:2 | LCMS |
Mannitol | LCMS |
Midazolam, Α-HYDROXYMIDAZOLAM | LCMS |
Milrinone | LCMS |
Monepantel and Monepantel Sulfone (exploratory) | LCMS |
Moxifloxacin | LCMS |
N-Acetylcysteine (total) | LCMS |
Nicotine | LCMS |
Nintedanib | LCMS |
Oxycodone and Noroxycodone | LCMS |
Oxycodone, Noroxycodone, Oxymorphone | LCMS |
Oxymorphone, 6-hydroxy beta oxymorphone | LCMS |
Paroxetine | LCMS |
Phenylalanine | LCMS |
Pravastatin | LCMS |
Progesterone (P4) | LCMS |
Psilocybin, Psilocin | LCMS |
Quinidine | LCMS |
Sildenafil | LCMS |
Sildenafil and Desmethyl Sildenafil | LCMS |
Tamoxifen and metabolites | LCMS |
Tenofovir | LCMS |
THC, CBD, CBN and two metabolites of THC | LCMS |
Vancomycin | LCMS |
DETERMINATION OF TOCILIZUMAB IN HUMAN SERUM USING THE GYROS IMMUNOASSAY PLATFORM | Immunoassay |
DETERMINATION OF OMALIZUMAB IN HUMAN SERUM USING THE GYROS IMMUNOASSAY PLATFORM | Immunoassay |
DETERMINATION OF USTEKINUMAB IN HUMAN SERUM USING THE GYROS IMMUNOASSAY PLATFORM | Immunoassay |
PBMC isolation | Cellular Molecular |